Business Description
Minerva Neurosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US6033801068
Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.72 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 5.7 | |||||
| 3-Year FCF Growth Rate | 29.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.76 | |||||
| 9-Day RSI | 44.8 | |||||
| 14-Day RSI | 39.68 | |||||
| 6-1 Month Momentum % | -36.74 | |||||
| 12-1 Month Momentum % | -63.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.58 | |||||
| Quick Ratio | 12.58 | |||||
| Cash Ratio | 12.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -54.62 | |||||
| ROIC % | -156.45 | |||||
| ROC (Joel Greenblatt) % | -185879.03 | |||||
| ROCE % | -41.86 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.76 | |||||
| EV-to-EBITDA | 0.76 | |||||
| EV-to-FCF | 0.84 | |||||
| Earnings Yield (Greenblatt) % | 131.58 | |||||
| FCF Yield % | -119.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Minerva Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -4.139 | ||
| Beta | -5.02 | ||
| Volatility % | 170.98 | ||
| 14-Day RSI | 39.68 | ||
| 14-Day ATR (€) | 0.060078 | ||
| 20-Day SMA (€) | 2.195 | ||
| 12-1 Month Momentum % | -63.55 | ||
| 52-Week Range (€) | 2.08 - 11.63 | ||
| Shares Outstanding (Mil) | 6.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Minerva Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Minerva Neurosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Minerva Neurosciences Inc Frequently Asked Questions
What is Minerva Neurosciences Inc(FRA:4MNA)'s stock price today?
The current price of FRA:4MNA is €2.16. The 52 week high of FRA:4MNA is €11.63 and 52 week low is €2.08.
When is next earnings date of Minerva Neurosciences Inc(FRA:4MNA)?
The next earnings date of Minerva Neurosciences Inc(FRA:4MNA) is 2024-05-15 Est..
Does Minerva Neurosciences Inc(FRA:4MNA) pay dividends? If so, how much?
Minerva Neurosciences Inc(FRA:4MNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers